Revista de la OFIL
ISSN 1699-714X ISSN 1131-9429
GALINDO BONILLA, PA et al. Home self-administration of biologics. A satisfaction survey in a severe asthma unit during a COVID-19 pandemic. []. , 33, 1, pp.41-46. 27--2023. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x2023000100008.
Objective:
To assess preferences and satisfaction of patients with severe asthma about the place of administration of subcutaneous biological drugs: hospital, health center and home, during the COVID-19 pandemic.
Methods:
Observational, descriptive and cross-sectional study that analyzed, from November 23 to 27, 2020, through a telephone survey, the preferences and degree of satisfaction with the administration of subcutaneous biological drugs in asthmatic patients treated in the Allergology consultation of a General Hospital
Results:
A total of 33 patients responded to the survey, the mean age was 51.5 years, 57.6% were women. The patients that received subcutaneous biological drugs (omalizumab, mepolizumab and benralizumab) at home were 57,6%, at the Day Hospital and at the Health Center 21,2 %, in both cases. The reasons for the administration outside the hospital were comfort and to avoid the spread of the SAR-CoV-2 virus (30.7%). After the pandemic, patients prefer home deliveries, self-administration and face-to-face medical consultations. The degree of satisfaction with the treatment was very high.
Conclusions:
Patients prefer to self-administer biological drugs for GA at home with the support of their home dispensing, showing a high degree of satisfaction with the comfort it provides. Once the pandemic is over, they demand that medical visits be face-to-face but they want to continue self-administering the drug after it is dispensed at home by the Pharmacy Service.
: Patient satisfaction; severe asthma; survey; Covid-19; biologics drugs; at home administration.